ICC Labs Inc. is the first integrated company dedicated to the production of cannabinoid extracts in South America. We are focused on becoming the worldwide leading producer of active pharmaceutical ingredients and end pharmaceutical products. Backed by scientific research and innovation, ICC Labs Inc. strives to provide full support and promote responsible use for medicinal purposes, while ensuring the strictest standards of compliance and following the highest standards of quality and safety. ICC Labs Inc. is a Canadian company with offices in British Columbia and operations in Uruguay, South America. In 2016 the company started trading on the Toronto Stock Exchange (TSX), under the ticker symbol "ICC". ICC Labs Inc. is committed to fostering collaboration between the scientific and academic communities, while pursuing innovation and development in the medical uses of cannabinoid extracts. We further leverage the therapeutic impact of cannabinoids by conducting clinical studies that aim to find novel ways of treating an ever-growing range of conditions. We are conscious of the environmental impact that human activity has on our ecosystem, and we are committed to the responsible management of natural resources and production processes. Our growth, innovation, and research initiatives involve assuming controlled risks and efficiently managing them. Furthermore, we are committed to delivering worthy results and value for our investors. Alejandro Antalich Chief Executive Officer